← Leaderboards
Joshua Alfaro
Pharmain Corporation
$1,990,199
Attributed
$1,990,199
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $995.1K · FY2023–24$1M$750K$500K$250K$0
'23
'24
Funding mix
By agency
NIH$1,990,199 · 1
By mechanism
R44$1,990,199 · 1
Top collaborators
No co-investigators on record.
Most similar at Pharmain Corporation
Same institution · by research overlap
- Gerardo M. Castillo$15,494,100
Others in their field
Other Rising Stars on “Acute”
- Taleen Hanania · Psychogenics, Inc.$9,482,040
- Gregory Sorenson · University Of Maryland Baltimore County$9,161,697
- Christopher J. Lindsell · Vanderbilt University Medical Center$8,536,327
- Michael E. Roth · Public Health Institute$8,201,777
- Jacob Sutton Coverstone · Neurovations$6,882,205
- Agustin G Yip · Albert Einstein College Of Medicine$6,090,308
Research focus
AcuteAdjuvant ChemotherapyAdolescentAnalytical MethodAntifibrotic TreatmentBoneCancer ModelCancer TypeCanis FamiliarisChemotherapyChestChildCisplatinClinical ResearchClinical TrialsC-Type Natriuretic PeptideCyclic GmpData SetDiagnosisDoseDoxorubicinEngineeringExcisionAccounting